Index | Hypertension goal achievement % (N) | LDL-C goal achievement % (N) | Both BP and LDL-C goal achievement % (N) |
---|---|---|---|

Total (n = 17,096)Age (years) | 31.9% (5450) | 60.1% (10,281) | 22.9% (3971) |

≥ 65 (n = 9769)
| 34.6% (3377) | 58.6% (5726) | 23.6% (2302) |

< 65 (n = 7327)
| 28.3% (2073) | 62.2% (4555) | 22.0% (1615) |

P-value
| < 0.001 | < 0.001 | 0.019 |

Duration of Hypertension^{a} (years)
| |||

< 5 (n = 5036)
| 34.8% (1754) | 63.8% (3212) | 26.0% (1310) |

≥ 5 (n = 10,588)
| 32.9% (3485) | 58.8% (6225) | 23.2% (2460) |

P-value
| 0.018 | < 0.001 | 0.001 |

BMI ≥ 28 kg/m^{2b}
| |||

Yes (n = 2658)
| 25.1% (667) | 55.8% (1482) | 17.4% (462) |

No (n = 14,432)
| 33.1% (4779) | 60.9% (8794) | 23.9% (3451) |

P-value
| < 0.001 | < 0.001 | < 0.001 |

Smoking | |||

Current smoker (n = 2105)
| 27.9% (587) | 59.4% (1250) | 20.0% (422) |

Previous smoker (n = 3099)
| 28.3% (876) | 63.6% (1972) | 20.4% (631) |

Non-smoker (n = 11,892)
| 33.5% (3987) | 59.4% (7059) | 24.1% (2864) |

P-value
| < 0.001 | 0.001 | < 0.001 |

Drinking alcohol | |||

Yes (n = 1572)
| 24.6% (387) | 59.2% (931) | 19.0% (298) |

No (n = 13,795)
| 33.4% (4602) | 60.1% (8285) | 23.8% (3288) |

Gave up drinking (n = 1729)
| 26.7% (461) | 61.6% (1065) | 19.1% (331) |

P-value
| < 0.001 | 0.347 | < 0.001 |

Sedentary lifestyle^{b}
| |||

Yes (n = 3595)
| 29.3% (1054) | 58.0% (2086) | 19.8% (712) |

No (n = 13,500)
| 32.6% (4396) | 60.7% (8195) | 23.7% (3205) |

P-value
| 0.000 | 0.004 | < 0.001 |

Family history of cardiovascular disease^{b}
| |||

Yes (n = 1744)
| 32.7% (570) | 60.8% (1060) | 23.2% (404) |

No (n = 15,348)
| 31.8% (4879) | 60.1% (9218) | 22.9% (3513) |

P-value
| 0.448 | 0.561 | 0.795 |

Comorbidities | |||

CKD (n = 1502)
| 19.8% (297) | 59.3% (890) | 14.8% (222) |

Diabetes (n = 6289)
| 16.8% (1059) | 46.0% (2895) | 9.3% (583) |

CHD (n = 6958)
| 20.3% (1410) | 54.9% (3821) | 12.8% (889) |

CVD (n = 3363)
| 28.4% (956) | 53.3% (1793) | 16.8% (566) |

Heart failure (n = 757)
| 25.8% (198) | 58.9% (452) | 17.1% (131) |

Peripheral vascular disease (n = 215)
| 22.3% (48) | 55.3% (119) | 13.5% (29) |

P-value
| < 0.001 | < 0.001 | < 0.001 |

Number of comorbidities | |||

0 (n = 4597)
| 58.8% (2703) | 76.7% (3525) | 48.3% (2219) |

1 (n = 7522)
| 24.3% (1830) | 57.0% (4289) | 15.3% (1152) |

2 (n = 3659)
| 18.3% (670) | 50.8% (1860) | 11.0% (403) |

≥ 3 (n = 1318)
| 18.7% (247) | 46.1% (607) | 10.8% (143) |

P-value
| < 0.001 | < 0.001 | < 0.001 |

Tier of Hospitals | |||

Tier 1 (n = 4117)
| 36.0% (1483) | 55.3% (2277) | 24.6% (1011) |

Tier 2 (n = 4433)
| 32.1% (1424) | 60.3% (2672) | 22.9% (1014) |

Tier 3 (n = 8546)
| 29.8% (2543) | 62.4% (5332) | 22.1% (1892) |

P-value
| < 0.001 | 0.010 | 0.010 |

Department | |||

General medicine (n = 4476)
| 34.0% (1520) | 53.1% (2375) | 21.5% (963) |

Geriatric (n = 2034)
| 36.9% (750) | 65.9% (1341) | 27.8% (566) |

Endocrine (n = 2246)
| 19.9% (446) | 48.9% (1098) | 12.4% (278) |

Neurology (n = 2062)
| 28.5% (588) | 58.6% (1208) | 19.5% (402) |

Cardiology (n = 5079)
| 32.0% (1626 | 67.8% (3444) | 25.2% (1282) |

Other^{c}(n = 1199)
| 43.4% (520) | 68.0% (815) | 35.5% (426) |

P-value
| < 0.001 | < 0.001 | < 0.001 |

Hypertension treatment | |||

Monotherapy (n = 8641)
| 36.2% (3125) | 58.9% (5091) | 25.9% (2241) |

Combination therapy (n = 6732)
| 32.4% (2184) | 63.4% (4268) | 23.6% (1591) |

P-value
| < 0.001 | < 0.001 | < 0.001 |